Cipdapla M 5mg/1000mg Tablet ER

Overview Cipdapla M 5mg/1000mg Tablet ER

Diabexe Duo 5mg/1000mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the risk of severe diabetic complications and contributing to heart health. Diabexe Duo may be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should not be discontinued without their consultation, as this could elevate blood sugar and increase the risk of complications such as kidney impairment and vision loss. This medication is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, queasiness, emesis, and loose stools. Adequate hydration is crucial to prevent dehydration. Genital yeast infections may occur; maintaining hygiene helps mitigate this risk. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or nursing individuals should seek medical counsel before use. Limit alcohol consumption, as it may heighten the likelihood of side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Cipdapla M 5mg/1000mg Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Cipdapla M 5mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Cipdapla M 5mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Cipdapla M 5mg/1000mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with food.

Common Side effects of Cipdapla M 5mg/1000mg Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Cipdapla M 5mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cipdapla M 5mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Cipdapla M 5mg/1000mg Tablet ER works:

Dapagliflozin and Metformin, combined as Cipdapla M 5mg/1000mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action leads to superior blood sugar regulation.

What if you forget to take Cipdapla M 5mg/1000mg Tablet ER :

Should you forget to take a Cipdapla M 5mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.